Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| PSA-M82Ea | Mouse | Biotinylated Mouse PSCA Protein, His,Avitag™, low endotoxin (MALS verified) |  |
||
| PSA-M82E3 | Mouse | Biotinylated Mouse PSCA Protein, His,Avitag™ (MALS verified) |  |
|
|
| PSA-H82E3 | Human | Biotinylated Human PSCA Protein, His,Avitag™ (MALS verified) |  |
|
|
| PSA-H52H6 | Human | Human PSCA Protein, His Tag |  |
|
2e5 of anti-PSCA CAR-293 cells were stained with 100 μL of 3 μg/mL of Biotinylated Human PSCA, His,Avitag (Cat. No. PSA-H82E3) and negative control protein respectively, washed and then followed by PE-SA antibody and analyzed with FACS (Routinely tested).
Immobilized Human PSCA, His Tag (Cat. No. PSA-H52H6) at 1 μg/mL (100 μL/well) can bind Anti-PSCA Antibody,Human IgG1 with a linear range of 0.2-1 ng/mL (QC tested).
The purity of Biotinylated Mouse PSCA, His,Avitag (Cat. No. PSA-M82Ea) is more than 95% and the molecular weight of this protein is around 18-26 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| MB-104 | MB-104; MB-105; MB-104 CS1 CAR; MB-105 PSCA CAR | Phase 2 Clinical | City Of Hope National Medical Center | Stomach Neoplasms; Glioblastoma; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Multiple Myeloma; Prostatic Neoplasms; Lymphoma, T-Cell | Details |
| Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (City of Hope Medical Center) | Phase 1 Clinical | City Of Hope National Medical Center | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
| 124-iodine-labeled PSCA targeting minibody (ImaginAb) | Phase 1 Clinical | University Of California At Los Angeles | Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms | Details | |
| anti-PSMA/anti-PSCA CAR T-cell therapy PD-1 silent (Shanghai Unicar-Therapy Bio-medicine) | Phase 1 Clinical | Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd | Hormone-Resistant Prostate Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
